NCT07164495 Risk Factors for Developing Peak Plantar Pressure During Walking in the Diabetic Patients
| NCT ID | NCT07164495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Diabete Type 2 |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-10-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate the clinically convenient dynamic and static measurement parameters to identify related risk factors of developing high peak plantar pressure during walking in the type-2 diabetic patients, and then establish a predictive model to estimate the likelihood of excessive plantar pressure. The main question it aims to answer is: Which clinical measurements may be used as the predictors that increased peak plantar pressure in the type-2 diabetic patients? Participants taking the examinations will understand their own clinally meaningful measurements related to their plantar pressure during walking. Further thorough analysis will be employed to develop a predictive model, aiming to provide potential improvement strategies for preventing diabetic foot ulcers in the future.
Eligibility Criteria
Inclusion Criteria: * diagnosed with type 2 diabetes, at least for five years * aged older than 18 years * walk independently for at least 10 meter without any assistive device Exclusion Criteria: * severe deformity in the foot or lower extremity * significant neuropathic or surgical diseases that affect normal walking function * cognitive dysfunction * active foot ulcer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07164495 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabete Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07164495 currently recruiting?
Yes, NCT07164495 is actively recruiting participants. Contact the research team at hclin@mail.cmu.edu.tw for enrollment information.
Where is the NCT07164495 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07164495 clinical trial?
NCT07164495 is sponsored by China Medical University Hospital. The trial plans to enroll 120 participants.